Pharmaceutical Executive
America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide.
Melanie Sena
Advertisement
Melanie Sena is community editor of Pharmaceutical Technology.
Articles by Melanie Sena
Advertisement
Latest Updated Articles
- 180 Diabetes Medicines in Development in the U.S.
February 18th 2014
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Trump Administration’s Leadership Carousel Across Key Agencies
3
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
4
Being Specific About Being General: Vaccines Edition
5